RHÖN-KLINIKUM Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Tobias Kaltenbach
Chief executive officer
€547.0k
Total compensation
| CEO salary percentage | 15.2% |
| CEO tenure | 1.3yrs |
| CEO ownership | n/a |
| Management average tenure | 3.5yrs |
| Board average tenure | 3.7yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | €32m |
| Jun 30 2023 | n/a | n/a | €26m |
| Mar 31 2023 | n/a | n/a | €30m |
| Dec 31 2022 | €547k | €83k | €25m |
Compensation vs Market: Tobias's total compensation ($USD593.15K) is below average for companies of similar size in the UK market ($USD1.36M).
Compensation vs Earnings: Insufficient data to compare Tobias's compensation with company performance.
CEO
Tobias Kaltenbach (63 yo)
1.3yrs
Tenure
€547,000
Compensation
Dr. Tobias Kaltenbach is Chief Executive Officer & Member of Management Board of RHÖN-KLINIKUM Aktiengesellschaft from November 2022. Mr. Kaltenbach served as Chairman of Corporate Management at Asklepios...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Management Board | 1.3yrs | €547.00k | no data | |
| CFO & Member of Management Board | 3.5yrs | €668.00k | no data | |
| COO & Member of Management Board | 5.8yrs | €708.00k | no data | |
| Head of Investor Relations & Treasury | no data | no data | no data | |
| Chief Representative | 3.6yrs | €219.00k | no data |
3.5yrs
Average Tenure
55yo
Average Age
Experienced Management: RHKd's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Member of Supervisory Board | 3.6yrs | €41.00k | no data | |
| First Deputy Chairman of the Supervisory Board | 13.8yrs | €62.00k | no data | |
| Member of Supervisory Board | 13.8yrs | €46.00k | no data | |
| Member of Supervisory Board | 6yrs | €36.00k | no data | |
| Member of Supervisory Board | 8.8yrs | €36.00k | no data | |
| Second Deputy Chairman of the Supervisory Board | 3.6yrs | €68.00k | no data | |
| Chairman of Supervisory Board | 3.8yrs | €107.00k | no data | |
| Member of Supervisory Board | 3.6yrs | €41.00k | no data | |
| Member of Supervisory Board | 3.6yrs | €46.00k | no data | |
| Member of Supervisory Board | 3.6yrs | €42.00k | no data | |
| Member of Supervisory Board | 3.8yrs | €30.00k | no data | |
| Member of Supervisory Board | 3.6yrs | €37.00k | no data |
3.7yrs
Average Tenure
Experienced Board: RHKd's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/03/20 10:11 |
| End of Day Share Price | 2023/12/22 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
RHÖN-KLINIKUM Aktiengesellschaft is covered by 36 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eileen Ryan | AlphaValue |
| Gerhard Schwarz | Baader Helvea Equity Research |
| Thomas Jones | Berenberg |